Repligen Corporation is yesterday's top mover after declining 11.09%
Leading equity indices in the US declined as after dropping 1.58%, S&P 500 closed at 4,071.63. Nasdaq slipped 1.98% and closed at 11,800.
Today's price action is taking place amid mixed market indicators – data for United States Core Durable Goods Orders published today at 12:30 UTC came out at 0.3%, beating projections of -0.2% and showing improvement over the preceding figure of -0.3%.
Assets that recorded the greatest percentage change in relation to their peers are designated as "Top Movers" with 's most active healthcare stocks listed below.
Bearish mood pushes Repligen Corporation to session low of $149.02
Yesterday's session continued down the same path: early in yesterday's session, Repligen Corporation dropped to $149.02 from $168.2 at the end of Monday, before closing at $149.55. During the session, it lost 11.09%.
Currently, the drug development enabler has a market capitalization of $8.32 billion with an average daily volume of 522,309 shares. So far this year, it has been under-performing the Nasdaq by 20.6%.
Adaptive Biotechnologies | Closed 81 cents (-9.82%) lower at $7.44
The immune-driven medicine pioneer is now trading 17.66% below its 3-month high of $12.67. Adaptive Biotechnologies has a market cap of $1 billion with an average daily trading volume of 822,879 shares. Adaptive Biotechnologies's last revenue report was $55.20 million with an EPS of -28 cents.
Elanco Animal Health lost 8.26% during yesterday's session; goes up in pre-market trading (+1.82% to $9.5)
After ending Monday at $10.17, Elanco Animal Health dropped to $9.33 early in yesterday's session and closed at $9.33. In total, it lost 8.26%. The US animal health company's market cap currently stands at $4.59 billion with an average daily trading volume of 7.25 million shares. So far this year, it has been doing worse than the Nasdaq by 36.58%.